Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Thorax
Journal
Overview
Identity
Overview
Publication Venue For
Structural airway imaging metrics are differentially associated with persistent chronic bronchitis
. 76:343-349.
2021
Respiratory exacerbations are associated with muscle loss in current and former smokers
2021
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study
. 75:808-811.
2020
Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits
. 75:520-527.
2020
Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years
. 73:414-421.
2018
Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults.
. 72:1113-1120.
2017
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial
. 72:318-326.
2017
Latent tuberculosis infection screening and treatment in HIV: Insights from evaluation of UK practice
. 72:180-182.
2017
Biomechanical CT metrics are associated with patient outcomes in COPD
. 72:409-414.
2017
Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis
. 71:1082-1090.
2016
β-Blockers are associated with a reduction in COPD exacerbations
. 71:8-14.
2016
Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia
. 70:41-47.
2015
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: Authors' response
. 69:1147-1148.
2014
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction
. 69:409-414.
2014
Progress in cystic fibrosis and the CF Therapeutics Development Network
. 67:882-890.
2012
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease
. 67:399-406.
2012
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
. 67:12-18.
2012
Genome-wide association study of smoking behaviours in patients with COPD
. 66:894-902.
2011
Intrapulmonary shunting associated with sildenafil treatment in a patient with idiopathic pulmonary arterial hypertension
. 66:1097-1098.
2011
PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice
. 66:788-796.
2011
Pneumocystis jirovecii in pleural infection: A nucleic acid amplification study
. 66:450-451.
2011
Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: Role of Hsp90 and Hsp70
. 65:346-353.
2010
Gastro-oesophageal reflux and aspiration in patients with advanced lung disease
. 64:167-173.
2009
Authors' response
. 63:1026.
2008
Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
. 63:301-305.
2008
Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients
. 63:154-159.
2008
Protection from experimental ventilator-induced acute lung injury by IL-1 receptor blockade
. 63:147-153.
2008
Authors' response
. 63:1027.
2008
Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis
. 63:935-936.
2008
Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy
. 62:964-968.
2007
Author's reply [6]
. 62:924.
2007
Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy
. 61:716-721.
2006
A&E department: A missed opportunity for diagnosis of TB? [4]
. 61:364-365.
2006
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection
. 61:791-794.
2006
Genotypic variation in Pneumocystis jirovecii isolates in Britain
. 60:679-682.
2005
Pneumocystis jirovecii infection
. 59:731-733.
2004
Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii (5) [multiple letters]
. 59:83-84.
2004
Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: A prospective study
. 58:594-597.
2003
Changes in nitric oxide synthase activity in the porcine lung after birth
. 53.
1998
Nebulisers for patients with HIV infection and AIDS
. 52.
1997
Alveolar lymphocytes and macrophages are an important source of HIV-1 in patients with AIDS
. 51.
1996
Genotypic variants of HIV-1 from peripheral blood and lung of AIDS patients
. 51.
1996
Authors' Reply
. 50:1227.
1995
Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200))
. 50:1228.
1995
Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200))
. 50:1228.
1995
Interstitial pneumonitis in patients infected with the human immunodeficiency virus
. 50:1141-1146.
1995
New developments in the pulmonary diseases affecting HIV infected individuals
. 50:294-302.
1995
Pneumocystis carinii pneumonia
. 50:191-200.
1995
Role of the human immunodeficiency virus within the lung
. 50:567-576.
1995
Community acquired lobar pneumonia in patients with HIV infection and AIDS
. 49:367-368.
1994
Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1
. 48:204-207.
1993
Histologically atypical Pneumocystis carinii pneumonia
. 48:996-1001.
1993
Bronchopulmonary Kaposi's sarcoma in patients with AIDS
. 47:721-725.
1992
Pneumocystis carinii pneumonia
. 47:305-314.
1992
Arterial desaturation in HIV positive patients undergoing sputum induction
. 46:449-451.
1991
AIDS and the lung: 5 - Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus
. 45:62-65.
1990
Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage (I: Reply)
. 45:302.
1990
Granulomatous Pneumocystis carinii pneumonia in a patient with the acquired immunodeficiency syndrome
. 45:769-771.
1990
Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia
. 45:140-146.
1990
Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage
. 44:554-558.
1989
Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
. 44:559-564.
1989
Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome
. 44:565-569.
1989
Infectious complications after heart transplantation
. 38:822-828.
1983
Technique, complications, and climncal value of endomyocardial biopsy in patients with heterotopic heart transplants
. 37:727-731.
1982
Empyema after internal jugular catheterisation in rheumatoid arthritis
. 36:958-959.
1981
Management of oesophageal perforation associated with benign stricture and hiatus hernia by oesophagoplasty and fundoplication
. 36:541-542.
1981
Pharmacological and hypothermic inhibition of metabolism during myocardial ischaemia
. 35:75.
1980
Collagen diseases as a cause of constrictive pericarditis
. 33:368-371.
1978
Incidence of postoperative infection and role of antibiotic prophylaxis in pulmonary surgery
. 33:130.
1978
Conservative surgery for bronchial adenomata
. 31:44-48.
1976
Transplantation of the heart and both lungs. I. Historical review.
. 24:383-390.
1969
Transplantation of the heart and both lungs. II. Experimental cardiopulmonary transplantation.
. 24:391-398.
1969
Identity
International Standard Serial Number (issn)
0040-6376
Electronic International Standard Serial Number (eissn)
1468-3296